Loading...
Market
How much will Baltimore secure from the remaining defendants in the opioid litigation by end of 2024?
3
Resolution / Starting Odds
Less than $50 million • 25%
$50 million to $100 million • 25%
$100 million to $150 million • 25%
More than $150 million • 25%
Official announcements from the City of Baltimore or court records
Story
Baltimore Settles with Teva, Walgreens for $160 Million in Opioid Crisis, Totaling $402.5 Million
Sep 10, 2024, 08:37 PM
The City of Baltimore has reached settlements with Teva Pharmaceuticals and Walgreens, totaling $160 million, for their roles in the city's opioid crisis. The settlement with Teva amounts to $80 million, while the settlement with Walgreens also amounts to $80 million. These settlements, announced on Monday and Tuesday, are part of a larger effort by Baltimore to address the opioid crisis, with the city securing a total of $402.5 million from various drug companies. The settlements come ahead of a trial scheduled to begin next week against the three remaining defendants in the litigation.
View original story
Similar markets
Less than $300M • 25%
$300M - $400M • 25%
$400M - $500M • 25%
More than $500M • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than $1 billion • 25%
$1 billion to $5 billion • 25%
More than $5 billion • 25%
No recovery • 25%
Johnson & Johnson • 25%
Teva Pharmaceuticals • 25%
Endo International • 25%
Other • 25%
Prevention programs • 25%
Treatment facilities • 25%
Public awareness campaigns • 25%
Other • 25%
Less than $1 billion • 25%
$1 billion to $1.5 billion • 25%
$1.5 billion to $2 billion • 25%
More than $2 billion • 25%
None • 25%
1-2 lawsuits • 25%
3-5 lawsuits • 25%
More than 5 lawsuits • 25%
McKesson • 25%
AmerisourceBergen • 25%
Johnson & Johnson • 25%
Other • 25%
Financial settlement reached • 25%
Case dismissed • 25%
Case goes to trial • 25%
Other • 25%